Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sterile alpha motif domain-containing protein 12 (SAMD12) is a nerve tissue protein encoded by the SAMD12 gene, containing a SAM domain. Its exact cellular and molecular function is not fully characterized, but it is implicated in cell surface receptor signaling and may play roles in cell proliferation and inhibition of apoptosis. Pathogenic pentanucleotide repeat expansions in its intronic regions (especially TTTCA insertions) are a causative genetic lesion in benign adult familial myoclonic epilepsy, making its mutation a distinctive diagnostic biomarker for this disease. While not categorized as a classical therapeutic target or receptor, SAMD12 is clinically relevant due to its role in neurodegenerative disease and its association with disease-specific genomic signatures[2][3][1].
None defined
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sterile alpha motif domain-containing protein 12 (SAMD12).